Key facts
- This page summarizes Jason Ehrlich's Form 4 filing for Kodiak Sciences Inc. (KOD).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 14 May 2021, 17:22.
Jason Ehrlich - 12 May 2021 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)
- Reporting relationship
- Chief Medical Officer and Chief Development Officer
- Issuer ticker
- KOD
- Reported as of
- 12 May 2021
- Net transaction value
- +$74,240
- SEC form
- 4
- Accepted by SEC
- 14 May 2021, 17:22:57 UTC
- Next SEC filing
- 24 May 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Carlton Fleming, Attorney-in-Fact for Jason Ehrlich
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jason Ehrlich filed Form 4 for Kodiak Sciences Inc. (KOD) on 14 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$74,240.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KOD
transaction
Common Stock
Options Exercise
- Transaction value
- $55,350
- Shares
- +5,379
- Change %
- +8.6%
- Price
- $10.29
- Shares after
- 68,222
- Date
- 12 May 2021
- Ownership
- Direct
KOD
transaction
Common Stock
Options Exercise
- Transaction value
- $18,890
- Shares
- +1,889
- Change %
- +2.8%
- Price
- $10.00
- Shares after
- 70,111
- Date
- 12 May 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KOD
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -5,379
- Change %
- -2%
- Price
- $0.000000
- Shares after
- 258,546
- Date
- 12 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,379
- Exercise price
- $10.29
- Footnotes
- F1
KOD
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,889
- Change %
- -3.3%
- Price
- $0.000000
- Shares after
- 54,793
- Date
- 12 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,889
- Exercise price
- $10.00
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.
Footnote F2
One-sixtieth of the shares subject to the option vested on November 3, 2018, and 1/60th of the shares subject to the option vest on the same day of each month thereafter.
SEC remarks
Chief Medical Officer and Chief Development Officer